MTOR and ovarian cancer: Apart from having prognostic impact our analysis also sheds light on previous unknown possible “druggable” targets in ovarian cancer; FKBP7, with the highest hazard ratio for individual genes in our study, appears to be especially of interest because FKBPs can be targeted with mTOR inhibitors [44].